---
title: "Kinco: Net profit of 26.1101 million yuan in the first half of 2025, a year-on-year increase of 13.58%"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/254966973.md"
description: "Kinco announced that its operating revenue in the first half of 2025 was 311 million yuan, a year-on-year increase of 21.28%. The net profit was 26.1101 million yuan, a year-on-year increase of 13.58%"
datetime: "2025-08-28T09:32:28.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/254966973.md)
  - [en](https://longbridge.com/en/news/254966973.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/254966973.md)
generator: "portal-rs"
---

# Kinco: Net profit of 26.1101 million yuan in the first half of 2025, a year-on-year increase of 13.58%

Kinco announced that its operating revenue in the first half of 2025 was 311 million yuan, a year-on-year increase of 21.28%. Net profit was 26.1101 million yuan, a year-on-year increase of 13.58%

### Related Stocks

- [688160.CN](https://longbridge.com/en/quote/688160.CN.md)

## Related News & Research

- [Helium Evolution financing creates three new 15% shareholders: Maxey, Tough Investments, Howard](https://longbridge.com/en/news/296842566.md)
- [Avanti Helium secures up to US $10 million convertible credit facility with RiverFort Global Opportunities](https://longbridge.com/en/news/296806980.md)
- [Cheng Shin Rubber: 2026H1 net income surged 43.8% year-over-year, driven by higher revenue and improved margins](https://longbridge.com/en/news/296745040.md)
- [Andfjord Salmon schedules Q2/H1 2026 results webcast and operational update](https://longbridge.com/en/news/296742723.md)
- [Lotus Lake portfolio company Immupeutics wins China IND clearance for IPM514 mRNA vaccine in lung squamous cancer](https://longbridge.com/en/news/296847935.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**